# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1032080 | F | Antibacterial activity against 0.01 MOI wild type Chlamydia psittaci 6BC BCRB infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia psittaci 6BC | 6 | organism-based format | Scientific Literature | ||
2. | ALA1032081 | F | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ2 harboring A2058C mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia psittaci 6BC | 6 | organism-based format | Scientific Literature | ||
3. | ALA1032859 | F | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ5 harboring A2059C mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia psittaci 6BC | 6 | organism-based format | Scientific Literature | ||
4. | ALA1032860 | F | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ1 harboring A2059G mutation in bacterial 23S rRNA gene infected in mouse L2 cells treated 2 hrs after infection measured on day 7 by plaque assay | Chlamydia psittaci 6BC | 6 | organism-based format | Scientific Literature | ||
5. | ALA1032861 | F | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ2 harboring A2058C mutation in bacterial 23S rRNA gene infected in mouse L2 cells assessed as growth of infectious particles at 200 ng/ml treated 2 hrs after infection measured after 14 days by plaque assay relative to control | Chlamydia psittaci 6BC | 1 | organism-based format | Scientific Literature | ||
6. | ALA1032862 | F | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ5 harboring A2059C mutation in bacterial 23S rRNA gene infected in mouse L2 cells assessed as growth of infectious particles at 200 ng/ml treated 2 hrs after infection measured after 14 days by plaque assay relative to control | Chlamydia psittaci 6BC | 1 | organism-based format | Scientific Literature | ||
7. | ALA1032863 | F | Antibacterial activity against azithromycin-resistant 0.01 MOI Chlamydia psittaci 6BC BCRBAZ1 harboring A2059G mutation in bacterial 23S rRNA gene infected in mouse L2 cells assessed as growth of infectious particles at 200 ng/ml treated 2 hrs after infection measured after 14 days by plaque assay relative to control | Chlamydia psittaci 6BC | 1 | organism-based format | Scientific Literature |